Search results
Results From The WOW.Com Content Network
A Medicine Company | Eli Lilly and Company. Learn the latest information on the availability of Lilly diabetes and obesity medicines. Learn how to protect yourself from counterfeit Mounjaro ® and Zepbound ® and unapproved tirzepatide products.
We’re a medicine company turning science into healing to make life better for people around the world. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges.
Join Our Talent Community. Find your place at Lilly with Lilly Careers. For more than a century, we have united caring with discovery to make life better, join us today.
The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.
For more than 145 years, we have worked tirelessly to develop and deliver trusted medicines and diagnostics that meet real needs. Our growing portfolio of medicines includes treatments in the areas of bone muscle joint, cancer, cardiovascular, diabetes, endocrine, immunology, neuroscience and obesity. The product information on this website is ...
Eli Lilly y Compañía es una empresa farmacéutica de alta especialidad fundada en 1876 que trabaja en el desarrollo de tratamientos en múltiples áreas terapéuticas. Diabetes, psoriasis, cáncer de mama, artritis reumatoide, migraña y más.
Key Facts. For nearly 150 years, we’ve made significant and game-changing progress on our mission to make life for people around the world. We’ve remained headquartered in Indianapolis, Indiana, since our founding on May 10, 1876, but our employees now work in countries around the world.
Hjemmeside for Eli Lilly and Company in Norway.
Press Releases. ALL CORPORATE FINANCIAL PRODUCT IMPACT ARCHIVE. New data show Lilly's EBGLYSS™ (lebrikizumab-lbkz) provided sustained disease control for up to three years in more than 80% of adults and adolescents with moderate-to-severe atopic dermatitis. September 25, 2024.
Lilly unites caring with discovery to create medicines that make life better for people around the world. Update: Mounjaro® (tirzepatide) Stock Availability Find out more